CD44 and breast carcinoma: Consistent with the prognostic significance of ESRP1 in breast cancer, ESRP1 was demonstrated to promote lung metastasis in orthotopic mouse model of breast cancer by regulating alternative splicing of CD44 mRNA [19, 20].